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he concept of endophenotypes in psychiatric dis-
orders has been developed over the last few decades.In
their 1967 paper on the genetics of schizophrenia,
Gottesman and Shields
1 used the term endophenotype to
define an illness-related characteristic,observable through
biochemical testing or microscopic examination. It is
assumed that a valid and useful endophenotype is more
closely related to one or more pathophysiological genes
for the nosological category, compared with the entire
spectrum of disorders included in the nosological category.
The utility of endophenotypes in psychiatric research is
now more appreciated because we have a more accurate
understanding of the genetic complexity of operationally
defined disorders in our current psychiatric nosology.
Endophenotypes should be valid approaches to creating
more homogeneous subtypes of current diagnostic cate-
gories.If endophenotypes can create more homogeneous
subgroups of the traditional nosology of schizophrenia
and affective disorders, then more rapid advances in
understanding these disorders at the genetic,molecular
level can be made.Improved pharmacotherapy would
surely follow.
Criteria for an endophenotype
The criteria for an endophenotype have been derived
from those proposed by Gershon and Goldin
2:
•The endophenotype must be associated with illness in
the general population.
•The endophenotype should be a stable,state-indepen-
dent characteristic (that is, it must be observable
despite the fact that the patient may be in partial or
complete remission).
•The endophenotype should be heritable.
•The endophenotype should segregate with illness
within families.
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This article reviews the concept of an endophenotype,
with particular reference to heritability as well as diag-
nostic specificity. An endophenotype need not be herita-
ble, for example, the possible influence of in utero viral
infections for schizophrenia. However, heritability is a use-
ful characteristic for a potential endophenotype, as it can
be studied in relation to a plausible candidate gene. It
should be noted that the traditional methods of demon-
strating heritability, eg, twin studies, can be supplemented
with DNA sequence studies, suggesting heritability.
Endophenotypes need not be specific to a given nosolog-
ical class of psychiatric disorders, as these classes do not
reflect biological categories. Evidence for two useful schiz-
ophrenia endophenotypes, the P50 abnormalities and
cognitive deficits, is summarized.  
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endophenotype,the endophenotype should be observ-
able at a higher rate among unaffected family members
compared with the general population.
In what follows below,we consider aspects of endophe-
notypes.
Diagnostic specificity for an endophenotype
The first criterion for an endophenotype is typically
proven by demonstrating that the endophenotype is
more common among unrelated people with a given
nosological diagnosis compared with the general popu-
lation.A related issue is diagnostic specificity.Should a
single endophenotype be specific to a given nosological
classification,such as schizophrenia or bipolar disorder?
While such a one-to-one correspondence might make for
easier comprehension of results,our current nosological
system,distinguishing schizophrenia and bipolar disor-
ders, is constructed on the basis of symptom clusters
and—to a lesser extent—the course of illness.The extent
to which our current nosological classification system
reflects biological distinctions is an unresolved matter.
Recent research suggests considerable overlap between
schizophrenia and bipolar disorder in family studies and
molecular studies (for reviews,see references 3 and 4).No
bipolar family study (that was conducted in an optimal
manner) reports increased risk for schizophrenia among
relatives of bipolar probands.Similarly,no schizophrenia
family study reports increased risk for bipolar disorders
among relatives of schizophrenia probands.However,sev-
eral schizophrenia family studies report increased risk for
recurrent unipolar depression and schizoaffective disor-
ders among relatives of schizophrenia probands.
5-8 Family
studies of bipolar illness show that a spectrum of mood
disorders is found among the first-degree relatives of bipo-
lar probands:bipolar I,bipolar II with major depression
(hypomania and depressive episodes in the same person),
schizoaffective disorders,and recurrent unipolar depres-
sion.
8-13 These family studies are consistent with some
degree of overlap in susceptibility to recurrent unipolar
depression and schizoaffective disorders for relatives of
bipolar probands and relatives of schizophrenia probands.
Kendler et al
7 specifically noted an increase in risk for psy-
chotic affective disorders among the relatives of schizo-
phrenia probands.Thus,from this family study perspective,
some endophenotypes may be shared between schizo-
phrenia and affective disorders.
Similarly,there is molecular evidence for genetic overlap
in susceptibility to schizophrenia and to affective disor-
ders (for a review,see reference 4).One promising can-
didate gene is the G72 locus on chromosomal region
13q32,the site of a confirmed linkage in bipolar disorder
and schizophrenia.
4 G72 is a primate-specific, brain-
expressed gene that activates D-amino acid oxidase.
14
D-Amino acid oxidase may control levels of D-serine,
which regulates glutamatergic receptors.
15 Chumakov et
al
14 identified a haplotype from G72 single nucleotide
polymorphisms (without obvious functional significance)
that were in linkage disequilibrium with schizophrenia in
a French-Canadian sample.This has been confirmed in
distinct schizophrenia populations,including Russian,
14
German,
16 Israeli,
17 and Chinese,
18 although different hap-
lotypes have been associated in distinct ethnic popula-
tions.Similarly,in bipolar disorder,there have been sev-
eral positive findings with distinct haplotypes in different
populations,including American
19,20 and German
16 bipo-
lar samples.Thus,from this molecular perspective,some
endophenotypes may be shared between schizophrenic
and affective disorders.
Given what we know about the overlap in genetic sus-
ceptibility to schizophrenia and mood disorders,
4 it is
entirely possible that some endophenotypes may be char-
acteristics of both types of disorder.
Stability and heritability of an endophenotype:
the P50 abnormalities as an example
Ideally,an endophenotype should be a stable,state-inde-
pendent parameter. An endophenotype should be an
enduring characteristic of an individual,and should be
present prior to the onset of illness.Thus,increased rates
of an endophenotype for schizophrenia should be
detectable when studying the young adult children of
schizophrenic persons.The same statement cannot be
made regarding an endophenotypic study of the prepu-
bertal children of schizophrenic individuals because it is
entirely possible that the endophenotype may not be
manifest until after puberty.This is particularly relevant
because schizophrenia is uncommon among prepubertal
children,but becomes common in young adults.
Increased rates of an endophenotype for schizophrenia
should be detectable when studying the individuals who
are acutely psychotic,as well as those in partial remission.
Similarly,an endophenotype for bipolar disorder should
be observable in the depressed,euthymic,or manic states.
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Consider one outstanding example of an endophenotype,
the P50 abnormality in schizophrenia.An abnormality of
the P50 auditory evoked potential is considered an endophe-
notype for schizophrenia.
21 The P50 wave is a positive
deflection (recorded by scalp electrodes) occurring 50 ms
after an auditory stimulus,typically a single click.When two
such clicks are presented,with the second click occurring
~200 ms after the first,the amplitude of the P50 wave after
the second click is reduced in comparison to the amplitude
of the wave after the first click (Figure 1).This is considered
to be an electrophysiological signature of sensory gating.In
some individuals with schizophrenia,the amplitude of the
p50 wave for the second click is similar to the amplitude
after the first click.This is interpreted as a failure of sensory
gating.This is shown in graphic form in Figure 1.
The P50 abnormality is found more often among individu-
als with schizophrenia,compared with controls,
22,23 although
this is not universally confirmed.
24,25The P50 abnormality is
found more frequently among the relatives of persons with
schizophrenia, compared to controls.
26,27 It is a heritable
characteristic,based on twin studies.
28,29 Heritability is also
implied by the reports that DNA sequence polymorphisms
in and near the α7-nicotinic receptor subunit gene on chro-
mosome 15 explain some of the variance in the P50 abnor-
mality.
30-32The chromosome 15 location is a confirmed link-
age region for schizophrenia,
33-36 thereby lending added
confidence to this line of investigation.
While there is ample evidence that the P50 is partially
under genetic control,
28-32 there is also substantial evidence
that P50 parameters are influenced by environmental
forces.For example,smoking or administration of nicotine
may “normalize” an abnormal P50 test.
37,38 The finding
becomes more intriguing when it is recalled that ~80% of
individuals with schizophrenia are daily smokers.
37
Additionally,there is evidence that atypical antipsychotic
medications can “normalize” abnormal P50 testing.
39-42
These results indicate a critical point when considering
endophenotypes:environmental influences must be con-
sidered,not only as sources of variance (eg,experimental
error,circadian variation,influence of personal habits such
as nicotine and caffeine intake),but also as clues to mech-
anisms that may provide pathways from gene variants to
endophenotypes,or from endophenotypes to key symp-
tom clusters or subtypes of disorders.
To summarize the P50 endophenotype literature,there is
substantial evidence that the P50 abnormality in schizo-
phrenia fulfills generally accepted criteria for an
endophenotype. Variation in or near the α7-nicotinic
receptor subunit gene may explain some of the genetic
variance in the P50 measurement, and additional
research with this endophenotype can be expected to
yield new insights into this subtype of schizophrenia.
Stability and heritability of an 
endophenotype: cognitive deficits in 
schizophrenia as an example
A second endophenotype that has been studied exten-
sively in schizophrenia is working memory.This term can
be defined as the holding of information in the conscious-
ness,in preparation for complex processing.Working mem-
ory can be assessed by multiple different mental tasks,such
as N back,Wisconsin Card Sort, and reverse digit span.
Deficits in working memory have been described as an
endophenotype for schizophrenia (for a review,see refer-
ence 43).The fraction of individuals with schizophrenia
who are designated as having abnormal working memory
varies with the tests employed,the clinical population stud-
ied,and the definition of abnormal (eg,1.5 or 2 standard
deviation units below the mean for controls).If consider-
ation is given only to studies of large numbers of cases
(~100) and controls,most reports describe 25% to 50% of
persons with schizophrenia as falling in the variably
defined “deficit range”for working memory.
44-49
Several lines of evidence suggest that the working mem-
ory deficits are partly heritable. Twin studies of unaf-
fected and discordant (for schizophrenia) monozygotic
and dizygotic twin pairs indicate that genetic influences
in the schizophrenia-related working memory deficits are
prominent.
50-53 In addition,multiple studies suggest that a
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Figure 1. The P50 abnormality in schizophrenia. In studying the P50 wave,
two clicks (~70 db) ~200 ms apart are used. Usually, the response
to the second click is reduced in amplitude, in comparison to the
response to the first click. In some persons with schizophrenia,
the amplitude of response to the second click is not reduced.
First
click
Second
click
Time
(ms)
µV
First
click
Control Schizophrenia
Second
clicksmall fraction of the variance in working memory scores
is explained by a functional variant in the catechol-O-
methyltransferase (COMT) gene,
54-56 although this find-
ing is not observed consistently.
57
Working memory deficits are more common among the
unaffected relatives (compared with controls) of schizo-
phrenic individuals who have deficits themselves (for a
review,see reference 8).The effect size for this observation
is relatively small,such that substantial sample numbers
are required to have adequate power.If only those studies
that examined at minimum ~50 relatives and ~50 controls
are considered,
58-65 then there is a preponderance of data
suggesting that unaffected relatives (of schizophrenic indi-
viduals) have some of the neuropsychological deficits seen
in affected persons.However,one must be concerned with
a negative publication bias,and with the fact that a wide
range of neuropsychological measures have been used,
such as Wisconsin Card Sort,digit span,trailmaking,tests
of verbal and spatial fluency,etc.The effect size is not large,
as evidenced by the fact that multiple smaller studies have
not found a significant difference between relatives of
schizophrenic individuals and controls.
66,67
The preponderance of data suggests that neuropsycho-
logical/cognitive deficits in schizophrenia are present
more often among affected persons compared with con-
trols.There are data to indicate that the measures are
heritable. Finally, most of the larger studies find that
nonpsychotic relatives of schizophrenic individuals score
more poorly on various neuropsychological tests com-
pared with controls.Thus,various measures of cognitive
function are valid endophenotypes for schizophrenia,on
the basis of the criteria noted above.
Promising endophenotype candidates 
lacking heritability data
Several potential endophenotypes for affective disorders
and schizophrenia lack sufficient heritability data. For
example,multiple central nervous system imaging studies
have revealed a failure to appropriately activate dorsolat-
eral prefrontal cortex while performing a Wisconsin Card
Sort task in some individuals with schizophrenia (for a
review,see reference 68).This promising endophenotype
lacks sufficient heritability data at present.Although there
is some evidence that a COMT functional variant is cor-
related with the endophenotype,
54 there is a need for sub-
stantial data on normal monozygotic and dizygotic twins.
One potentially useful endophenotype for affective disor-
ders may be the magnetic resonance imaging finding of sub-
cortical (white matter) hyperintensities among bipolar
patients.
69-77 Multiple investigators have observed hyperin-
tensities among bipolar patients more often and with
greater severity,compared with control values.
69-77Two meta-
analyses
78,79 of white matter hyperintensities in bipolar dis-
order were consistent with an odds ratio of ~3.2,suggesting
that bipolar patients had a greater number of such lesions
compared with age- and sex-matched controls.However,
there are no genetic studies of white matter hyperintensi-
ties,so that heritability remains unknown.Complicating this
limitation is the fact that the severity of white matter hyper-
intensities increases with age and cardiovascular disease risk
factors,
80 a finding that suggests that the hyperintensity
images are related to ischemia,which was an early hypoth-
esis concerning these magnetic resonance images.
81 One
hypothesis that deserves further exploration is that the
ischemia producing the white matter hypertensities in bipo-
lar disorder is related to central nervous system mitochon-
drial abnormalities.
82-84 Mitochondrial dysfunction could
mimic ischemia,in that neuronal cells could be “starved”of
oxygen,since the mitochondria are less than normally effi-
cient in producing adenosine triphosphate (ATP).
Is heritability an essential criterion for an
endophenotype?
Although heritability is considered to be one criterion for
an endophenotype,this may not be an essential charac-
teristic of all valid endophenotypes. For example, it has
been hypothesized that viral infections in utero may be an
environmental risk factor for schizophrenia,
85-87 although
many studies have been unable to confirm this association
(for a review,see reference 88).While this may be a valid
endophenotype,it is difficult to consider this as a heritable
characteristic,because the increase in risk after in utero
infection has been documented for influenza
85,87 and for
rubella.
86Thus,some endophenotypes may not have heri-
table components, but may be valid means for creating
subgroups of cases.This does not mean that any means to
create subgroups of patients represents an endopheno-
type.To subgroup schizophrenia patients as having suf-
fered an in utero viral infection, one must first develop
some biochemical test to determine if a given schizo-
phrenic person has experienced such an infection. Once
that test is in place,one can then attempt to define whether
a particular genetic background of schizophrenia risk is
more common among these unique cases. ❏
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Bases genéticas para los endofenotipos en
los trastornos psiquiátricos
Este artículo revisa el concepto de endofenotipo,
con especial atención a la heredabilidad como tam-
bién a la especificidad diagnóstica. Un endofeno-
tipo no requiere necesariamente ser heredable,
como ocurre por ejemplo en la posible influencia
de infecciones virales intrauterinas para la esquizo-
frenia. Sin embargo, la heredabilidad es una carac-
terística útil para un potencial endofenotipo, pues
se puede estudiar en relación con un posible gen
candidato. Se debe tener en consideración que los
métodos tradicionales para demostrar la heredabi-
lidad, como los estudios en gemelos, se pueden
complementar con estudios de secuencias de ADN,
que sugieren heredabilidad. Los endofenotipos no
requieren ser específicos para determinadas clases
nosológicas o trastornos psiquiátricos, ya que estas
clases no reflejan categorías biológicas. Se resumen
las evidencias para dos endofenotipos útiles en la
esquizofrenia, como son las anormalidades de la
onda P50 y los déficits cognitivos. 
Bases génétiques des endophénotypes dans
les troubles psychiatriques
Cet article passe en revue le concept d’un endo-
phénotype avec une référence particulière à l'héri-
tabilité aussi bien qu’à une spécificité diagnostique.
Un endophénotype n’est pas nécessairement à
transmission héréditaire, par exemple, l’infection
virale in utero, endophénotype possible pour la
schizophrénie. Toutefois, l'héritabilité est un carac-
tère utile pour un endophénotype potentiel, car il
peut être étudié avec un gène candidat plausible.
Il faudrait noter que les méthodes traditionnelles
de démonstration de l'héritabilité, par exemple les
études concernant les jumeaux, peuvent être com-
plétées de l’étude des séquences d’ADN, suggérant
l'héritabilité. Il n’est pas nécessaire que les endo-
phénotypes soient spécifiques d’une classe nosolo-
gique donnée de troubles psychiatriques, ces classes
ne reflétant pas des catégories biologiques. Nous
allons résumer les arguments pour deux endophé-
notypes utiles pour la schizophrénie, le P50 et le
déficit cognitif.
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